Lenz Therapeutics Inc (LENZ)
$3.05 -12.61% Close Oct 30, 2026 Live
Lenz Therapeutics stock today
Lenz Therapeutics closed at $3.05 on October 30, 2026, down 12.61% on the day. Over the past year it returned -90.0% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $96.0 million.
$10.00$20.00$30.00
NovJan 2026MarMayJulSep
| Period | LENZ | S&P 500 (SPY) |
|---|---|---|
| 1 month | -20.6% | -0.9% |
| 3 months | -47.0% | +2.1% |
| Year to date | -80.9% | +11.7% |
| 1 year | -90.0% | +12.4% |
| 3 years | -74.5% | +88.5% |
| 5 years | -95.2% | +76.0% |
Key statistics
- Market value
- $96.0M
- Price / sales
- 4.5
- 52-week range
- $3.05 to $31.94
About Lenz Therapeutics
Lenz Therapeutics develops pharmaceutical treatments for circadian rhythm and sleep disorders.
Sector: Health Care
More on Lenz Therapeutics
- Returns: what $1,000 became$1,000 five years ago is $47.59 today
No forecast, no recommendation. This page describes Lenz Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.